High level of CFTR expression is associated with tumor aggression and knockdown of CFTR suppresses proliferation of ovarian cancer in vitro and in vivo

Xu,Jiao; Yong,Min; Li,Jia; Dong,Xiaojing; Yu,Tinghe; Fu,Xiao; Hu,Lina

doi:10.3892/or.2015.3829

High level of CFTR expression is associated with tumor aggression and knockdown of CFTR suppresses proliferation of ovarian cancer in vitro and in vivo

Authors:
- Jiao Xu
- Min Yong
- Jia Li
- Xiaojing Dong
- Tinghe Yu
- Xiao Fu
- Lina Hu
View Affiliations

Affiliations: Department of Obsterics and Gynecology, The Second Affiliated Hospital of Chongqing Medical University, Chongqing 400010, P.R. China, Department of Pathology, The Second Affiliated Hospital of Chongqing Medical University, Chongqing 400010, P.R. China, Laboratory of Obsterics and Gynecology, The Second Affiliated Hospital of Chongqing Medical University, Chongqing 400010, P.R. China
Published online on: March 3, 2015 https://doi.org/10.3892/or.2015.3829
Pages: 2227-2234

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The cystic fibrosis transmembrane conductance regulator (CFTR) belongs to the ATP-binding cassette (ABC) transporter family, members of which are involved in various types of cancer. The relationship between CFTR and ovarian cancer remains to be elucidated. The aim of the present study was to investigate the expression of CFTR in human ovarian cancer tissues and its clinical significance in the progression of ovarian cancer. The role of CFTR in the malignant invasion, migration and proliferation of ovarian cancer in vitro and in vivo was also investigated. Immunohistochemical staining analysis was performed to detect the expression of CFTR in 83 cases of human epithelial ovarian cancer specimens. Moreover, SKOV3 and A2780 stable cell lines containing shRNA gene specific for CFTR were established. Cell proliferation and motility were observed and compared with CFTR-RNAi cells. Tumorigenicity of CFTR-RNAi cells was investigated by tumor xenograft experiments conducted subcutaneously in nude mice. The expresssion of CFTR in ovarian cancer was significantly higher than that in benign ovarian tumor and normal ovaries (P<0.05). In ovarian cancer, CFTR expression was significantly associated with advanced FIGO stage, poor histopathological grade and serum Ca-125 (P<0.05). Furthermore, we observed that CFTR staining was stronger in the serous type as compared to the other types (P<0.05). Compared with the negative control, decreased cell invasion, migration, proliferation, adhesion and colony formation were observed in CFTR-RNAi cells in vitro. In vivo, tumorigenic abilities of CFTR-RNAi cells were significantly repressed compared with that of the control groups. CFTR overexpression may play an important role in the development and progression of ovarian cancer. Additionally, the downregulation of CFTR suppresses aggressive malignant biological behaviors of ovarian cancer cells in vitro and in vivo.

View Figures

View References

1	Siegel R, Naishadham D and Jemal A: Cancer statistics, 2013. CA Cancer J Clin. 63:11–30. 2013. View Article : Google Scholar : PubMed/NCBI
2	Rauh-Hain JA, Krivak TC, Del Carmen MG and Olawaiye AB: Ovarian cancer screening and early detection in the general population. Rev Obstet Gynecol. 4:15–21. 2011.PubMed/NCBI
3	Bear CE, Li CH, Kartner N, et al: Purification and functional reconstitution of the cystic fibrosis transmembrane conductance regulator (CFTR). Cell. 68:809–818. 1992. View Article : Google Scholar : PubMed/NCBI
4	Tizzano EF, Silver MM, Chitayat D, Benichou JC and Buchwald M: Differential cellular expression of cystic fibrosis transmembrane regulator in human reproductive tissues. Clues for the infertility in patients with cystic fibrosis. Am J Pathol. 144:906–914. 1994.PubMed/NCBI
5	Schwiebert EM, Benos DJ, Egan ME, Stutts MJ and Guggino WB: CFTR is a conductance regulator as well as a chloride channel. Physiol Rev. 79(Suppl 1): S145–S166. 1999.PubMed/NCBI
6	Higgins CF: ABC transporters: from microorganisms to man. Annu Rev Cell Biol. 8:67–113. 1992. View Article : Google Scholar : PubMed/NCBI
7	Padua RA, Warren N, Grimshaw D, et al: The cystic fibrosis ΔF508 gene mutation and cancer. Hum Mutat. 10:45–48. 1997. View Article : Google Scholar
8	Neglia JP, FitzSimmons SC, Maisonneuve P, et al: The risk of cancer among patients with cystic fibrosis. Cystic Fibrosis and Cancer Study Group. N Engl J Med. 332:494–499. 1995. View Article : Google Scholar : PubMed/NCBI
9	Mcwilliams RR, Petersen GM, Rabe KG, et al: Cystic fibrosis transmembrane conductance regulator (CFTR) gene mutations and risk for pancreatic adenocarcinoma. Cancer. 116:203–209. 2010.
10	Qiao D, Yi L, Hua L, et al: Cystic fibrosis transmembrane conductance regulator (CFTR) gene 5T allele may protect against prostate cancer: a case-control study in Chinese Han population. J Cyst Fibros. 7:210–214. 2008. View Article : Google Scholar
11	Li Y, Sun Z, Wu Y, et al: Cystic fibrosis transmembrane conductance regulator gene mutation and lung cancer risk. Lung Cancer. 70:14–21. 2010. View Article : Google Scholar : PubMed/NCBI
12	Xie C, Jiang XH, Zhang JT, et al: CFTR suppresses tumor progression through miR-193b targeting urokinase plasminogen activator (uPA) in prostate cancer. Oncogene. 32:2282–2291. 2291.e1–2291.e7. 2013. View Article : Google Scholar
13	Zhang JT, Jiang XH, Xie C, et al: Downregulation of CFTR promotes epithelial-to-mesenchymal transition and is associated with poor prognosis of breast cancer. Biochim Biophys Acta. 1833:2961–2969. 2013. View Article : Google Scholar : PubMed/NCBI
14	Wu Z, Peng X, Li J, Zhang Y and Hu L: Constitutive activation of nuclear factor κB contributes to cystic fibrosis transmembrane conductance regulator expression and promotes human cervical cancer progression and poor prognosis. Int J Gynecol Cancer. 23:906–915. 2013. View Article : Google Scholar : PubMed/NCBI
15	Jacquot J, Tabary O, Le Rouzic P and Clement A: Airway epithelial cell inflammatory signalling in cystic fibrosis. Int J Biochem Cell Biol. 40:1703–1715. 2008. View Article : Google Scholar : PubMed/NCBI
16	Au CW, Siu MK, Liao X, et al: Tyrosine kinase B receptor and BDNF expression in ovarian cancers - effect on cell migration, angiogenesis and clinical outcome. Cancer Lett. 281:151–161. 2009. View Article : Google Scholar : PubMed/NCBI
17	Wang J, Dai JM, Che YL, et al: Elmo1 helps dock180 to regulate Rac1 activity and cell migration of ovarian cancer. Int J Gynecol Cancer. 24:844–850. 2014. View Article : Google Scholar : PubMed/NCBI
18	Singh AP, Chauhan SC, Andrianifahanana M, et al: MUC4 expression is regulated by cystic fibrosis transmembrane conductance regulator in pancreatic adenocarcinoma cells via transcriptional and post-translational mechanisms. Oncogene. 26:30–41. 2007. View Article : Google Scholar
19	Peng X, Wu Z, Yu L, et al: Overexpression of cystic fibrosis transmembrane conductance regulator (CFTR) is associated with human cervical cancer malignancy, progression and prognosis. Gynecol Oncol. 125:470–476. 2012. View Article : Google Scholar : PubMed/NCBI
20	Moyer BD, Denton J, Karlson KH, et al: A PDZ-interacting domain in CFTR is an apical membrane polarization signal. J Clin Invest. 104:1353–1361. 1999. View Article : Google Scholar : PubMed/NCBI
21	Brdicková N, Brdicka T, Andera L, et al: Interaction between two adapter proteins, PAG and EBP50: a possible link between membrane rafts and actin cytoskeleton. FEBS Lett. 507:133–136. 2001. View Article : Google Scholar : PubMed/NCBI
22	Wiener JR, Windham TC, Estrella VC, et al: Activated Src protein tyrosine kinase is overexpressed in late-stage human ovarian cancers. Gynecol Oncol. 88:73–79. 2003. View Article : Google Scholar
23	Wiener JR, Nakano K, Kruzelock RP, Bucana CD, Bast RC Jr and Gallick GE: Decreased Src tyrosine kinase activity inhibits malignant human ovarian cancer tumor growth in a nude mouse model. Clin Cancer Res. 5:2164–2170. 1999.PubMed/NCBI
24	Kim HS, Han HD, Armaiz-Pena GN, et al: Functional roles of Src and Fgr in ovarian carcinoma. Clin Cancer Res. 17:1713–1721. 2011. View Article : Google Scholar : PubMed/NCBI